6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05128175 (ClinicalTrials.gov)	October 29, 2021	27/10/2021	Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and F ...	An Open-label, Balanced, Randomized, Five-treatment, Five-period, Five-sequence, Multiple Oral Dose, ...	Parkinson Disease	Drug: WD-1603 Carbidopa-Levodopa Extended-Release Tablets	Shanghai WD Pharmaceutical Co., Ltd.	NULL	Recruiting	18 Years	45 Years	All	15	Phase 1	India
2	NCT05036473 (ClinicalTrials.gov)	October 12, 2021	10/8/2021	A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With P ...	A Phase II Randomized, Parallel, Double-blind, Placebo-controlled, Multi-center Clinical Trial of th ...	Parkinson Disease	Drug: WD-1603 Carbidopa-Levodopa Extended-Release Tablets;Drug: Placebo	Shanghai WD Pharmaceutical Co., Ltd.	NULL	Recruiting	30 Years	75 Years	All	40	Phase 2	China

First Previous1Next Last